Trellus Health (LSE:TRLS) NonCurrent Deferred Revenue: £0.00 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Trellus Health NonCurrent Deferred Revenue?

Trellus Health LSE:TRLS NonCurrent Deferred Revenue is £0.00 Mil as of Jun. 2025. The stock has 2 warning signs investors should review.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

Trellus Health's non-current deferred revenue for the quarter that ended in Jun. 2025 was £0.00 Mil.

Trellus Health NonCurrent Deferred Revenue Related Terms

Trellus Health NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Trellus Health's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trellus Health NonCurrent Deferred Revenue Chart

Trellus Health Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
NonCurrent Deferred Revenue
0.00 0.00 0.00 0.00 0.00

Trellus Health Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
NonCurrent Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
What does a NonCurrent Deferred Revenue of £0.00 Mil mean?
Trellus Health (LSE:TRLS) has a NonCurrent Deferred Revenue of £0.00 Mil as of Jun. 2025. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Trellus Health and its competitors.
Is Trellus Health's NonCurrent Deferred Revenue too high?
Trellus Health's current NonCurrent Deferred Revenue is £0.00 Mil.
How does Trellus Health's NonCurrent Deferred Revenue compare to VEEV and BTSG?
Trellus Health's NonCurrent Deferred Revenue of £0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Healthcare Providers & Services company?
A good NonCurrent Deferred Revenue depends on the Healthcare Providers & Services industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Trellus Health and its competitors. Trellus Health's current NonCurrent Deferred Revenue is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trellus Health stock overvalued right now?
Trellus Health (LSE:TRLS) has a current NonCurrent Deferred Revenue of £0.00 Mil. The current NonCurrent Deferred Revenue is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For Trellus Health (LSE:TRLS), the current NonCurrent Deferred Revenue is £0.00 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Trellus Health Business Description

Other Exchanges 85Q:Germany
Address 19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.